Now, with the addition of neuro-oncologists Robert Aiken, M.D., and Nicholas Metrus, M.D., the center’s multidisciplinary panel of experts stands at the pinnacle of excellence in treating benign and cancerous tumors of the brain, skull base, spine, and spinal cord.
Dr. Aiken will serve as co-medical director with neurosurgeon Yaron Moshel, M.D., Ph.D., who has held this position since the center’s opening in 2018. A devoted researcher and educator, Dr. Aiken was previously director of neuro-oncology at Rutgers Cancer Institute of New Jersey.
“Overlook has built a program that puts patients and families at the center of everything. We offer the nation’s top medical experts, the latest image-guided surgical techniques, neuropathology that plays a key role in developing personalized tumor treatment plans, the region’s largest and most experienced CyberKnife® program, advanced clinical trials, and complementary integrative therapies – all in one convenient location.”Neuro-oncologist
Dr. Metrus completed his fellowship training at MD Anderson Cancer Center in Houston, where he was the recipient of several research grants and published works on advances in clinical trial design for brain tumors.
“I think we’re on the cusp of some big breakthroughs in the field of neuro-oncology and patients here will have access to novel therapies under investigation. We are not only following best practices in neurological care, we are helping to pioneer them.”Neuro-oncologist
Learn more in the Spring 2021 issue of the Gerald J. Glasser Brain Tumor Center newsletter.